Want to track IMNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immunome Inc. (IMNM) Statistics
Valuation metrics
Market Cap 2.16B
Enterprise value 1.55B
Trailing P/E (ttm) -9.34
Forward P/E -
PEG ratio -0.33
Price/Sales (ttm) 531.43
Price/Book (mrq) 4.29
Enterprise Value/Revenue 387.22
Enterprise Value/EBITDA -7.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 688.43K
Average volume (90 days) 1.13M
Price summary
52-Week low 8.66
52-Week high 27.65
Beta -
50-Day moving average 20.73
200-Day moving average 22.22
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -55.94%
Operating margin -59.48%
Operational effectiveness
Return on assets -0.36%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.15
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 21.68%
Book value per share (mrq) 5.2
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
